|
Volumn 19, Issue 23, 2009, Pages 6691-6695
|
Discovery of pyrimidine benzimidazoles as Src-family selective Lck inhibitors. Part II
|
Author keywords
Autoimmune disease; Kinase inhibitor; Lck inhibitor; Pyrimidine benzimidazoles; Transplantation rejection
|
Indexed keywords
4 AMINO 6 BENZIMIDAZOLE PYRIMIDINE DERIVATIVE;
BENZIMIDAZOLE DERIVATIVE;
PROTEIN KINASE INHIBITOR;
PROTEIN KINASE LCK INHIBITOR;
PROTEIN TYROSINE KINASE;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ARTICLE;
CELL PROLIFERATION;
DRUG BINDING;
DRUG DESIGN;
DRUG SYNTHESIS;
ENZYME ACTIVITY;
ENZYME INHIBITION;
IC 50;
MOUSE;
NONHUMAN;
STRUCTURE ACTIVITY RELATION;
ANIMALS;
BENZIMIDAZOLES;
CELL LINE;
CELL PROLIFERATION;
DRUG DESIGN;
DRUG DISCOVERY;
LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK);
MICE;
MODELS, MOLECULAR;
MOLECULAR STRUCTURE;
PROTEIN KINASE INHIBITORS;
PYRIMIDINES;
STEREOISOMERISM;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 71749086550
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmcl.2009.09.123 Document Type: Article |
Times cited : (9)
|
References (11)
|